p8

Polydendritic Nano-Adjuvant

Perpetuum starts pre-clinical stage investigation of it’s proprietary Polydendritic Nano-Adjuvants for novel vaccination strategies.

Ombium Launch

Perpetuum launches it’s new brand Ombium, a nutritional supplement line targeting metabolic syndrome risk factors.

Dermium Launch

Perpetuum set to launch the world’s first acne treatment based on it’s recombinant bacteriophage endolysin technology

China Division

Perpetuum opens new division in China for the sales of it’s cosmetic consumer brands throughout APAC.